Page 194 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice

184 ELECTROLYTE DISORDERS

225. Greenlee PG, Filippa DA, Quimby FW, et al. Lymphomas 245. Hickford FH, Stokol T, van Gessel YA, et al. Monoclonal
in dogs: a morphologic, immunologic, and clinical study. immunoglobulin G cryoglobulinemia and multiple mye-
Cancer 1990;66:480–90. loma in a domestic shorthair cat. J Am Vet Med Assoc
226. Grone A, McCauley LK, Capen CC, et al. Cloning and 2000;217:1029–33.
sequencing of the 3 -region of the canine parathyroid hor- 246. Hilbe M, Sydler T, Fischer L, et al. Metastatic calcification
0
mone-related protein gene and analysis of alternate in a dog attributable to ingestion of a tacalcitol ointment.
mRNA splicing in two canine carcinomas. Domest Anim Vet Pathol 2000;37:490–2.
Endocrinol 2002;22:169–77. 247. Hill RC, Van Winkle TJ. Acute necrotizing pancreatitis
227. Grosenbaugh DA, Gadawski JE, Muir WW. Evaluation of and acute suppurative pancreatitis in the cat. A retrospec-
a portable clinical analyzer in a veterinary hospital setting. tive study of 40 cases (1976-1989). J Vet Intern Med
J Am Vet Med Assoc 1998;213:691–4. 1993;7:25–33.
228. Gunther R, Felice LJ, Nelson RK, et al. Toxicity of a vita- 248. Hirt RA, Kneissl S, Teinfalt M. Severe hypercalcemia in a
min D3 rodenticide to dogs. J Am Vet Med Assoc dog with a retained fetus and endometritis. J Am Vet Med
1988;193:211–4. Assoc 2000;216:1423–5.
229. Gutierrez O, Isakova T, Rhee E, et al. Fibroblast growth 249. Hoare SR, Usdin TB. Molecular mechanisms of ligand
factor-23 mitigates hyperphosphatemia but accelerates recognition by parathyroid hormone 1 (PTH1) and
calcitriol deficiency in chronic kidney disease. J Am Soc PTH2 receptors. Curr Pharm Des 2001;7:689–713.
Nephrol 2005;16:2205–15. 250. Hodges RD, Legendre AM, Adams LG, et al.
230. Gwaltney-Brant S, Holding JK, Donaldson CW, et al. Itraconazole for the treatment of histoplasmosis in cats.
Renal failure associated with ingestion of grapes or raisins J Vet Intern Med 1994;8:409–13.
in dogs. J Am Vet Med Assoc 2001;218:1555–6. 251. Hofer AM, Brown EM. Extracellular calcium sensing and
231. Habener JF, Rosenblatt M, Potts Jr JT. Parathyroid hor- signalling. Nat Rev Mol Cell Biol 2003;4:530–8.
mone: biochemical aspects of biosynthesis, secretion, 252. Holick MF. Noncalcemic actions of 1,25-dihydrox-
action, and metabolism. Physiol Rev 1984;64:985–1053. yvitamin D3 and clinical applications. Bone 1995;17
232. Halabe A, Arie R, Mimran D, et al. Hypoparathyroidism: (Suppl.):107S–111S.
a long-term follow-up experience with 1 alpha-vitamin 253. Holick MF. Photobiology of vitamin D. In: Feldman D,
D3 therapy. Clin Endocrinol (Oxf) 1994;40:303–7. editor. Vitamin D. New York: Academic Press; 1997.
233. Ham K, Greenfield CL, Barger A, Schaeffer D, p. 33–40.
Ehrhart EJ, Pinkerton M, et al. Validation of a rapid para- 254. Holick MF. Vitamin D: importance in the prevention of
thyroid hormone assay and intraoperative measurement of cancers, type 1 diabetes, heart disease, and osteoporosis.
parathyroid hormone in dogs with benign naturally occur- Am J Clin Nutr 2004;79:362–71.
ring primary hyperparathyroidism. Vet Surg 2009;38 255. Holley DC, Evans JW. Determination of total and
(1):122–32. ultrafilterable calcium and magnesium in normal equine
234. Hare WR, Dobbs CE, Slayman KA, et al. Calcipotriene serum. Am J Vet Res 1977;38:259–62.
poisoning in dogs. Vet Med 2000;95:770–8. 256. Hollis BW, Kamerud JQ, Kurkowski A, et al. Quantifica-
235. Harrison HE, Harrison HC. Transfer of Ca45 across tion of circulating 1,25-dihydroxyvitamin D by radioim-
intestinal wall in vitro in relation to action of vitamin D munoassay with 125I-labeled tracer. Clin Chem
and cortisol. Am J Physiol 1960;199:265–71. 1996;42:586–92.
236. Haruna A, Kawai K, Takab T, et al. Dietary calcinosis in 257. Holowaychuk MK, Hansen BD, DeFrancesco TC,
the cat. J Anim Clin Res Round 1992;1:9–16. Marks SL. Ionized hypocalcemia in critically ill dogs.
237. Haussler MR, Haussler CA, Jurutka PW, et al. The nuclear J Vet Intern Med 2009;23(3):509–13.
vitamin D receptor: from clinical radioreceptor assay of 258. Hori Y, Uechi M, Kanakubo K, Sano T, Oyamada T.
the vitamin D hormone to genomics, proteomics and a Canine ovarian serous papillary adenocarcinoma with
novel ligand. J Clin Ligand Assay 2002;25:221–8. neoplastic hypercalcemia. J Vet Med Sci 2006;68
238. Hayes CE, Nashold FE, Spach KM, et al. The immuno- (9):979–82.
logical functions of the vitamin D endocrine system. Cell 259. Horn B, Irwin PJ. Transient hypoparathyroidism follow-
Mol Biol (Noisy-le-grand) 2003;49:277–300. ing successful treatment of hypercalcaemia of malignancy
239. Hazewinkel HA, Tryfonidou MA. Vitamin D3 metabo- in a dog. Aust Vet J 2000;78:690–2.
lism in dogs. Mol Cell Endocrinol 2002;197:23–33. 260. Horst RL, Reinhardt TA, Hollis BW. Improved method-
240. Hazewinkel HAW. Dietary influences on calcium ology for the analysis of plasma vitamin D metabolites.
homeostasis and the skeleton. In: Purina International Kidney Int Suppl 1990;29:S28–S35.
Nutrition Symposium. Orlando, Fla: Ralston Purina; 261. Horst RL, Reinhardt TA. Vitamin D metabolism. In:
1991. p. 52. Feldman D, editor. Vitamin D. New York: Academic
241. Henderson RA, Powers RD, Perry L. Development of Press; 1997. p. 13–31.
hypoparathyroidism after excision of laryngeal rhabdo- 262. Hostutler RA, Chew DJ, Jaeger JQ, et al. Uses and effec-
myosarcoma in a dog. J Am Vet Med Assoc tiveness of pamidronate disodium for treatment of dogs
1991;198:639–43. and cats with hypercalcemia. J Vet Intern Med
242. Henry DA, Goodman WG, Nudelman RK, et al. Paren- 2005;19:29–33.
teral aluminum administration in the dog: I. Plasma kinet- 263. Hostutler RA, DiBartola SP, Chew DJ, et al. Comparison
ics, tissue levels, calcium metabolism, and parathyroid of the effects of daily and intermittent-dose calcitriol on
hormone. Kidney Int 1984;25:362–9. serum parathyroid hormone and ionized calcium
243. Henry H. The 25-hydroxyvitamin D 1-alpha-hydroxy- concentrations in normal cats and cats with chronic renal
lase. In: Feldman D, editor. Vitamin D. New York: Aca- failure. J Vet Intern Med 2006;20:1307–13.
demic Press; 1997. p. 57–68. 264. How KL, Hazewinkel HA, Mol JA. Dietary vitamin D
244. Hess RS, Saunders HM, Van Winkle TJ, et al. Concurrent dependence of cat and dog due to inadequate cutaneous
disorders in dogs with diabetes mellitus: 221 cases (1993- synthesis of vitamin D. Gen Comp Endocrinol
1998). J Am Vet Med Assoc 2000;217:1166–73. 1994;96:12–8.